56
Views
2
CrossRef citations to date
0
Altmetric
Review

Recent developments in the treatment of acute abdominal and facial attacks of hereditary angioedema: focus on human C1 esterase inhibitor

, &
Pages 133-146 | Published online: 03 Dec 2010

References

  • PowellRJDu ToitGLSiddiqueNBSACI guidelines for the management of chronic urticaria and angio-oedemaClin Exp Allergy200737563165017456211
  • GrigoriadouSLonghurstHJClinical immunology review series: an approach to the patient with angio-oedemaClin Exp Immunol2009155336737719220828
  • FrankMM8. Hereditary angioedemaJ Allergy Clin Immunol2008121 Suppl 2S398S40118241690
  • GompelsMMLockRJAbinunMC1 inhibitor deficiency: consensus documentClin Exp Immunol2005139337939415730382
  • BorkKBarnstedtSEKochPTraupeHHereditary angioedema with normal C1-inhibitor activity in womenLancet2000356922521321710963200
  • KaplanAPGhebrehiwetBThe plasma bradykinin-forming pathways and its interrelationships with complementMol Immunol201047132161216920580091
  • BinkleyKEFactor XII mutations, estrogen-dependent inherited angioedema, and related conditionsAllergy Asthma Clin Immunol2010611620667119
  • TosiMMolecular genetics of C1 inhibitorImmunobiology199811923583659777419
  • RocheOBlanchACaballeroTSastreNCallejoDLópez-TrascasaMHereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in SpainAnn Allergy Asthma Immunol200594449850315875532
  • WeilerCRvan DellenRGGenetic test indications and interpretations in patients with hereditary angioedemaMayo Clin Proc200681795897216835976
  • BrickmanCMTsokosGCBalowJEImmunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune diseaseJ Allergy Clin Immunol19867757497573084606
  • BowenTCicardiMFarkasH2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedemaAllergy Asthma Clin Immunol2010612420667127
  • BasMAdamsVSuvoravaTNiehuesTHoffmannTKKojdaGNonallergic angioedema: role of bradykininAllergy200762884285617620062
  • NzeakoUCFrigasETremaineWJHereditary angioedema: a broad review for cliniciansArch Intern Med20011612417242911700154
  • BorkKMengGStaubachPHardtJHereditary angioedema: new findings concerning symptoms, affected organs, and courseAm J Med2006119326727416490473
  • ZurawBLClinical practice. Hereditary angioedemaN Engl J Med2008359101027103618768946
  • CunninghamDSJensenJTHereditary angioneurotic edema in the puerperium. A case reportJ Reprod Med19913643123132072364
  • FrankMMGelfandJAAtkinsonJPHereditary angioedema: the clinical syndrome and its managementAnn Intern Med19768455805931275365
  • FrankMMEffect of sex hormones on the complement-related clinical disorder of hereditary angioedemaArthritis Rheum1979221112951299508378
  • BorumMLHowardDEHereditary angioedema. Complex symptoms can make diagnosis difficultPostgrad Med199810342512552569553599
  • ByrdJBAdamABrownNJAngiotensin-converting enzyme inhibitor-associated angioedemaImmunol Allergy Clin North Am200626472573717085287
  • KempJGCraigTJVariability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature reviewAllergy Asthma Proc200930549349919843403
  • PappalardoECicardiMDuponchelCFrequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedemaJ Allergy Clin Immunol200010661147115411112899
  • BorkKHypovolemic shock caused by ascites in hereditary angioedemaMed Klin (Munich)19989395549792023
  • KrauseKHRentropUMehreganUCerebral manifestations in angioneurotic edemaJ Neurol Sci1979423429435512675
  • BrettleRPDunmowREMilneLAYapPLAngioneurotic oedema in the elderlyScott Med J19822743093117146879
  • ThorvaldssonSESedlackREGleichGJRuddySJAngioneurotic edema and deficiency of C’1 esterase inhibitor in a 61-year-old womanAnn Intern Med19697123533575800297
  • LandermanNSHereditary angioneurotic edema. I. Case reports and review of the literatureJ Allergy19623331632914461961
  • AgostoniACicardiMHereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patientsMedicine (Baltimore)19927142062151518394
  • CicardiMCastelliRZingaleLCAgostoniASide effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patientsJ Allergy Clin Immunol19979921941969042044
  • FrankMMSergentJSKaneMAAllingDWEpsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind studyN Engl J Med1972286158088124551861
  • GelfandJASherinsRJAllingDWFrankMMTreatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalitiesN Engl J Med19762952614441448792688
  • FrankMMHereditary angioedema: the clinical syndrome and its management in the United StatesImmunol Allergy Clin North Am200626465366817085283
  • ShefferALAustenKFRosenFSTranexamic acid therapy in hereditary angioneurotic edemaN Engl J Med197228794524544558045
  • GrattanCEHBlackAKUrticaria and mastocytosisBurnsTBreathnachSCoxNGriffithsGRook’s Textbook of Dermatology8th edOxfordWiley-Blackwell201022.2122.22
  • LaurentJGuinnepainMTAngioedema associated with C1 inhibitor deficiencyClin Rev Allergy Immunol199917451352310829818
  • ShefferALFearonDTAustenKFClinical and biochemical effects of stanozolol therapy for hereditary angioedemaJ Allergy Clin Immunol19816831811876790595
  • BorkKPittonMHartenPKochPHepatocellular adenomas in patients taking danazol for hereditary angio-oedemaLancet199935391581066106710199359
  • SzéplakiGVargaLValentinSAdverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedemaJ Allergy Clin Immunol2005115486486915806011
  • SloaneDELeeCWShefferALHereditary angioedema: safety of long-term stanozolol therapyJ Allergy Clin Immunol2007120365465817765757
  • BorkKBygumAHardtJBenefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patientsAnn Allergy Asthma Immunol2008100215316118320917
  • BuamahPKAn apparent danazol-induced primary hepatocellular carcinoma: case reportJ Surg Oncol19852821141162578590
  • WeillBJMenkèsCJCormierCLouvelADougadosMHoussinDHepatocellular carcinoma after danazol therapyJ Rheumatol1988159144714492848945
  • CramponDBarnoudRDurandMDanazol therapy: an unusual aetiology of hepatocellular carcinomaJ Hepatol1998296103510369875659
  • ConfavreuxCSèvePBroussolleCRenaudierPDucerfCDanazol-induced hepatocellular carcinomaQJM200396431731812651980
  • FarkasHVargaLSzéplakiGVisyBHarmatGBowenTManagement of hereditary angioedema in pediatric patientsPediatrics20071203e713e72217724112
  • BouilletLHereditary angioedema in womenAllergy Asthma Clin Immunol2010611720667120
  • JaffeCJAtkinsonJPGelfandJAFrankMMHereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgeryJ Allergy Clin Immunol19755563863931138015
  • BowenTCicardiMBorkKHereditary angioedema: a current state-of-the-art review. VII. Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary AngioedemaAnn Allergy Asthma Immunol2008100 1 Suppl 2S30S4018220150
  • EwaldGAEisenbergPRPlasmin-mediated activation of contact system in response to pharmacological thrombolysisCirculation199591128367805216
  • LynchMPentecostBLLittlerWAStockleyRAWhy do patients develop reactions to streptokinase?1993942279285
  • FrancisCWBrennerBLeddyJPMarderVJAngioedema during therapy with recombinant tissue plasminogen activatorBr J Haematol19917745625631902745
  • ZurawBLChristiansenSCNew promise and hope for treating hereditary angioedemaExpert Opin Investig Drugs2008175697706
  • DonaldsonVHEvansRRA biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C’1-esteraseAm J Med196335374414046003
  • LandermanNSWebsterMEBeckerELRatcliffeHEHereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikreinJ Allergy19623333034114461960
  • PickeringRJGoodRAKellyJRGewurzHReplacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasmaLancet1969175903263304179348
  • PremattaMGibbsJGPrattELStoughtonTRCraigTJFresh frozen plasma for the treatment of hereditary angioedemaAnn Allergy Asthma Immunol200798438338817458436
  • ZurawBLDiagnosis and management of hereditary angioedema: an American approachTransfus Apher Sci200329323924514572816
  • ZurawBLCurrent and future therapy for hereditary angioedemaClin Immunol20051141101615596404
  • VogelaarEFBrummelhuisHGKrijnenHWContributions to the optimal use of human blood. 3. Large-scale preparation of human C1 esterase inhibitor concentrate for clinical useVox Sang19742621181274207849
  • de SerresJGronerALindnerJSafety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a reviewTransfus Apher Sci200329324725414572817
  • LeviMChoiGPicavetCHackCESelf-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiencyJ Allergy Clin Immunol2006117490490816630950
  • Pastó-CardonaLBordas-OrpinellJMercadal-OrfilaGPérez de la VaraAJódar-MassanésRProfilaxis y tratamiento del angioedema hereditario y adquirido en el HUB; utilización del inhibidor de la C1-esterasaFarm Hosp (Madrid)2003276346352
  • Aygoren-PursunEMartinez-SaguerIRusickeEKlingebielTKreuzWOn demand treatment and home therapy of hereditary angioedema in Germany – the Frankfurt experienceAllergy Asthma Clin Immunol2010612120667124
  • CicardiMZingaleLHow do we treat patients with hereditary angioedemaTransfus Apher Sci200329322122714572813
  • CicardiMZingaleLCZanichelliADeliliersDLCacciaSThe use of plasma-derived C1 inhibitor in the treatment of hereditary angioedemaExpert Opin Pharmacother20078183173318118035961
  • SchulteUHofmannPStability of a New Formulation of C1-esterase-inhibitor Concentrate at Room TemperatureInternational Clinical Practice SeriesTunbridge Wells (Kent)Wells Medical, Ltd2004
  • Martinez-SaguerIHellerCFischerDEttingshausenCEKreuzWProphylactic treatment with pasteurized C1 inhibitor in hereditary angioedema (HAE) – a prospective 32 months follow upBlood199994 Suppl 12339
  • BorkKBarnstedtSETreatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedemaArch Intern Med2001161571471811231704
  • US Food and Drug Administration (FDA)FDA Approves Berinert to Treat Abdominal Attacks, Facial Swelling Associated with Hereditary Angioedema Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm186257.htmAccessed 2010 Oct 21.
  • Martinez-SaguerIRusickeEAygören-PürsünEvon HentigNKlingebielTKreuzWPharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective studyTransfusion201050235436019788511
  • KunschakMEnglWMaritschFA randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedemaTransfusion19983865405499661687
  • LehmannALangJBoldtJSaggauWSuccessful off-pump coronary artery bypass graft surgery in a patient with hereditary angioedemaJ Cardiothorac Vasc Anesth200216447347612154430
  • AlvarezJMSuccessful use of C1 esterase inhibitor protein in a patient with hereditary angioneurotic edema requiring coronary artery bypass surgeryJ Thorac Cardiovasc Surg2000119116817110612778
  • Martinez-SaguerIHellerCKreuzWContinuous infusion of a pasteurized C1 inhibitor concentrate in patients with severe hereditary angioedema (HAE)Eur J Pediatr1999158 Suppl 3S211S220
  • BernsteinJARitchieBLevyRJPopulation pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacksAnn Allergy Asthma Immunol2010105214915420674826
  • BernsteinJAHereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapiesAnn Allergy Asthma Immunol20081001 Suppl 2S41S4618220151
  • AgostoniABergamaschiniLMartignoniGCicardiMMarasiniBTreatment of acute attacks of hereditary angioedema with C1-inhibitor concentrateAnn Allergy19804452993016155097
  • GadekJEHoseaSWGelfandJAReplacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitorN Engl J Med1980302105425467351888
  • WaytesATRosenFSFrankMMTreatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrateN Engl J Med199633425163016348628358
  • CraigTJLevyRJWassermanRLEfficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacksJ Allergy Clin Immunol2009124480180819767078
  • GoodmanSLevyRWassermanRC1 esterase inhibitor (C1-INH) concentrate in the treatment of acute attacks in hereditary angioedema: interim results of the treatment of 975 attacks in an ongoing, prospective, open-label study in North America (I.M.P.A.C.T.2)J Allergy Clin Immunol20101252 Suppl 1AB166
  • ViroPharma Incorporated (VPHM.OQ) Key Developments Reuters.comAccessed 2010 Aug 30
  • ZurawBLBussePJWhiteMNanofiltered C1 inhibitor concentrate for treatment of hereditary angioedemaN Engl J Med2010363651352220818886
  • van DoornMBBurggraafJvan DamTA phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedemaJ Allergy Clin Immunol2005116487688316210064
  • ChoiGSoetersMRFarkasHRecombinant human C1-inhibitor in the treatment of acute angioedema attacksTransfusion20074761028103217524093
  • ZurawBLHAE therapies: past present and futureAllergy Asthma Clin Immunol2010612320667126
  • EidelmanFJHereditary angioedema: new therapeutic options for a potentially deadly disorderBMC Blood Disord201010320470390
  • http://www.biospace.com/news_story.aspx?NewsEntityId=185307Accessed 2010 Sep 3.
  • ZurawBLChristiansenSCNew promise and hope for treating hereditary angioedemaExpert Opin Investig Drugs200817697706
  • LevyRMcNeilDLiHHsuFIHornPRobertsJResults of a 2-stage, phase 3 pivotal trial, EDEMA3: a study of subcutaneous DX-88 (Ecallantide), a plasma kallikrein inhibitor, in patients with hereditary angioedema (HAE)J Allergy Clin Immunol20081212 Suppl 1S231
  • BantaECraigTHornPTPullmanWETime of intervention with ecallantide for the treatment of acute attacks of hereditary angioedema: results from the edema development programAnn Allergy2009103A131A132
  • DeeksEDIcatibantDrugs2010701738120030426
  • CHMP assessment report for Firazyr http://www.ema.europa.eu/ema/index.jsp?curl=pages/home/Home_Page.jspAccessed 2010 Oct 26.
  • CicardiMBanerjiABrachoFIcatibant, a new bradykinin-receptor antagonist, in hereditary angioedemaN Engl J Med2010363653254120818888
  • BouilletLBocon-GibodIPonardDBradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacksAnn Allergy Asthma Immunol2009103544819927548
  • BossiFFischettiFRegoliDNovel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiencyJ Allergy Clin Immunol2009124613031310e419796797